eMDR System Enhancements
The FDA recognizes the importance of providing early notice and predictability about potential eMDR system changes, especially for high-volume submitters. Therefore, the FDA is implementing enhancements to the eMDR System on a regular schedule.
Firms that utilize third party applications to create eMDR submission files should use the information on this page to plan system updates to align with these eMDR system enhancements as soon as possible. Low-volume firms should note that the FDA eSubmitter client is updated concurrently with the eMDR system.
Through this schedule, the FDA expects to take the next steps for every cycle of new enhancements:
- Announce upcoming enhancements in June,
- Release the Implementation Package in August,
- Deploy enhancements to pre-production (ESG NextGen Test) in September, and
- Deploy high-impact enhancements to production 7 months after the Implementation Package is released, typically in March of the following year.
While the FDA expects to follow this schedule for future enhancements, it is possible that emergency fixes may need to be implemented outside the schedule. Additionally, if major system changes are necessary in the future, additional time will be provided between release of the implementation package and production deployment.
We will provide regular communications on this page at each point in the process. This information will also be emailed to the CDRH Industry's email list.
Please contact the eMDR helpdesk at MDRTHelpdesk@fda.hhs.gov for any questions or concerns about specifications and enhancements. Industry may use eMDR Test for testing system updates at any time.
Upcoming Enhancements to eMDR
| Change | Comments | Schedule |
|---|---|---|
| eMDR consolidation with Adverse Event Monitoring System (AEMS) | To provide additional information on the AEMS announcement for AS2/API submitters (eSubmitter users will not be affected):
| May 11, 2026: Test deployment to eMDR. May 31, 2026: Production deployment to eMDR. |
| No longer accepting ISO 3166-1 alpha-2 country codes | With the AEMS consolidation, eMDR will begin rejecting ISO 3166-1 alpha-2 country codes, which are not compliant with the XML specification. AS2/API submitters should use Geopolitical Entities, Names and Codes (GENC) 3-letter country codes in their submissions. While FIPS 10-4 codes are currently accepted, they were withdrawn in 2008 and are no longer recommended for use. These requirements have been documented in the eMDR Implementation Package since 2020. | May 11, 2026: Test deployment to eMDR. May 31, 2026: Production deployment to eMDR |
| International Medical Device Regulators Forum (IMDRF) 2025 maintenance updates | The Adverse Event codes accepted in sections F10 and H6 of the Form 3500A were updated to harmonize with maintenance updates from IMDRF in Fall 2025. A summary of the changes and the new hierarchy file have been released at Coding Resources for Medical Device Reports. | September 26, 2025: Test deployment to eMDR. October 6, 2025: Users (including eSubmitter) can begin using the new codes. AS2/API users to implement the new codes by March 31, 2027. |
| International Medical Device Regulators Forum (IMDRF) 2026 maintenance updates | The Adverse Event codes accepted in sections F10 and H6 of the Form 3500A will be updated to harmonize with maintenance updates from IMDRF. A summary of the changes and the new hierarchy file will be released in August 2026 at Coding Resources for Medical Device Reports. | September 2026: Test deployment to eMDR. October 2026: Users (including eSubmitter) can begin using the new codes. AS2/API users to implement the new codes by March 31, 2027. |
List of Historical eMDR Changes
| Change | Comments |
|---|---|
| 2024 eMDR Enhancements |
|
| 2023 eMDR Enhancements |
|
| 2022 eMDR Enhancements |
|
| 2021 eMDR Enhancements |
|
| 2020 eMDR Enhancements |
|
| 2018 eMDR Enhancements |
|
| 2017 eMDR Enhancements |
|